To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
MPM leads largest European VC financing of year
UK-based drug development company Oxagen has received almost £32m in a series B round of financing led by MPM Capital in its first European investment.
